optimum < option < optional

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 25.
[0-20] [0 - 20][0 - 25][20-24][20-40]

Ident.	Authors (with country if any)	Title
000012 (2005)	Norihiro Nishimoto [Japon]	Clinical studies in patients with Castleman’s disease, Crohn’s disease, and rheumatoid arthritis in Japan
000027 (2010)	Taio Naniwa [Japon] ; Rei Ito [Japon] ; Maiko Watanabe [Japon] ; Yoshihito Hayami [Japon] ; Shinji Maeda [Japon] ; Kaneshige Sasaki [Japon] ; Shiho Iwagaitsu [Japon]	Case report: successful use of short-term add-on tocilizumab for multirefractory systemic flare of adult-onset Still’s disease
000043 (2009)	Kazuko Matsumoto [Japon] ; Takao Nagashima [Japon] ; Shino Takatori [Japon] ; Yuta Kawahara [Japon] ; Masaki Yagi [Japon] ; Masahiro Iwamoto [Japon] ; Hitoaki Okazaki [Japon] ; Seiji Minota [Japon]	Glucocorticoid and cyclosporine refractory adult onset Still’s disease successfully treated with tocilizumab
000074 (2010)	Keiichi Sumida [Japon] ; Yoshifumi Ubara [Japon] ; Junichi Hoshino [Japon] ; Tatsuya Suwabe [Japon] ; Rikako Hiramatsu [Japon] ; Eiko Hasegawa [Japon] ; Noriko Hayami [Japon] ; Masayuki Yamanouchi [Japon] ; Naoki Sawa [Japon] ; Fumi Takemoto [Japon] ; Kenmei Takaichi [Japon]	Etanercept-refractory adult-onset Still’s disease with thrombotic thrombocytopenic purpura successfully treated with tocilizumab
000120 (2011)	Rene Thonhofer [Autriche] ; Manuela Hiller [Autriche] ; Horst Just [Autriche] ; Markus Trummer [Autriche] ; Cornelia Siegel [Autriche] ; Christian Dejaco [Autriche]	Treatment of refractory adult-onset still’s disease with tocilizumab: report of two cases and review of the literature
000130 (2007)	Gerald Gartlehner [Autriche, États-Unis] ; Richard A. Hansen [États-Unis] ; Beth L. Jonas [États-Unis] ; Patricia Thieda [États-Unis] ; Kathleen N. Lohr [États-Unis]	Biologics for the treatment of juvenile idiopathic arthritis: a systematic review and critical analysis of the evidence
000135 (2012)	K. Krüger [Allemagne] ; J. Wollenhaupt [Allemagne] ; K. Albrecht [Allemagne] ; R. Alten [Allemagne] ; M. Backhaus [Allemagne] ; C. Baerwald [Allemagne] ; W. Bolten [Allemagne] ; J. Braun [Allemagne] ; H. Burkhardt [Allemagne] ; G. Burmester [Allemagne] ; M. Gaubitz [Allemagne] ; A. Gause [Allemagne] ; E. Gromnica-Ihle [Allemagne] ; H. Kellner [Allemagne] ; J. Kuipers [Allemagne] ; A. Krause [Allemagne] ; H.-M. Lorenz [Allemagne] ; B. Manger [Allemagne] ; H. Nü Lein [Allemagne] ; H.-G. Pott [Allemagne] ; A. Rubbert-Roth [Allemagne] ; M. Schneider [Allemagne] ; C. Specker [Allemagne] ; H. Schulze-Koops [Allemagne] ; H.-P. Tony [Allemagne] ; S. Wassenberg [Allemagne] ; U. Müller-Ladner [Allemagne]	S1-Leitlinie der DGRh zur sequenziellen medikamentösen Therapie der rheumatoiden Arthritis 2012
000238 (2012)	H. G. Nü Lein [Allemagne]	Wie früh würden wir Biologika wirklich einsetzen?
000239 (2012)	S. Kleinert [Allemagne] ; H. P. Tony [Allemagne]	Rheumatische Erkrankungen mit Erstmanifestation im mittleren Lebensalter
000247 (2011)	Bruce H. Littman [États-Unis]	An NIH National Center for Advancing Translational Sciences: is a focus on drug discovery the best option?
000265 (2009)	Margaret Hy [Royaume-Uni] ; Ernest Hs Choy [Royaume-Uni]	Certolizumab pegol: a new option for rheumatoid arthritis
000282 (2010)	Gert Hein [Allemagne] ; Thorsten Eidner [Allemagne] ; Peter Oelzner [Allemagne] ; Michael Rose [Allemagne] ; Alexander Wilke [Allemagne] ; Gunter Wolf [Allemagne] ; Sybille Franke [Allemagne]	Influence of Rituximab on markers of bone remodeling in patients with rheumatoid arthritis: a prospective open-label pilot study
000337 (2011)	Sylvie Fabre [France]	Approches pharmacologiques en immuno-rhumatologie
000466 (2009)	Taio Naniwa [Japon] ; Maiko Watanabe [Japon] ; Shogo Banno [Japon] ; Tomoyo Maeda [Japon]	Adding low dose tacrolimus in rheumatoid arthritis patients with an inadequate response to tumor necrosis factor inhibitor therapies
000549 (2013)	D. Rossi [Italie] ; S. Sciascia [Italie] ; E. Manna [Italie] ; G. B. Binello [Italie] ; V. Modena [Italie] ; D. Roccatello [Italie]	AB0707 Tocilizumab as a therapeutic option for rhupus patients refractory to conventional therapy
000697 (2010)	M. Rihl [Allemagne] ; J. G. Kuipers [Allemagne]	Reaktive Arthritis
000A50 (2011)	Jisna R. Paul [États-Unis] ; Prabha Ranganathan [États-Unis]	Clinical trials in rheumatoid arthritis: a status report from the ClinicalTrials.gov website
000C25 (2009)	Jacques Biot ; Christelle Fasano ; Céline Dos Santos	D’orthoclone au dénosumab
000C86 (2013)	Goohyeon Hong [Corée du Sud] ; Hojoong Kim [Corée du Sud, États-Unis]	Clinical characteristics and treatment outcomes of patients with relapsing polychondritis with airway involvement
000D21 (2006)	Hiok Hee Chng [Singapour]	Management of systemic lupus erythematosus in the coming decade: potentials and challenges
000E75 (2012)	Jie Fan [République populaire de Chine] ; Huiting Zhou [République populaire de Chine] ; Shihui Wang [République populaire de Chine] ; Hailian Wang [République populaire de Chine] ; Yushun Zhang [République populaire de Chine] ; Yingtao Guo [République populaire de Chine] ; Qing Li [République populaire de Chine] ; Zhongjun Li [République populaire de Chine] ; Zhihui Zhao [République populaire de Chine]	Therapeutic effects of lactosyl derivative Gu-4 in a collagen-induced arthritis rat model

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "option" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "option" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    option
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021